Skip to product information
1 of 1

HealthExecStore

Webinar: Hospital Price Transparency Implications: Fallout from the CMS Final Rule Effective in 2021

Webinar: Hospital Price Transparency Implications: Fallout from the CMS Final Rule Effective in 2021

Regular price $215.00 USD
Regular price Sale price $215.00 USD
Sale Sold out

Please join us on Thursday, February 6, 2020, at 1 PM Eastern as Epstein Becker Green's Stephanie W. Kanwit examines the provisions, complexities, challenges, implications and outcomes of the CMS Hospital Price Transparency Final Rule, in this special 45-minute HealthcareWebSummit event: Hospital Price Transparency Implications: Fallout from the CMS Final Rule Effective in 2021.

Overview

Webinar: Thursday, February 6, 2020, at 1 PM - 1:45 PM Eastern

  • The provisions set forth in the CMS Hospital Transparency Final Rule
  • The complexities surrounding the scope of the Final Rule
  • The challenge of making a hospital’s negotiated rates “consumer friendly”
  • Illustrative examples in the application of risk adjustment
  • Practical implications and outcomes for hospitals, consumers, and regulators

Faculty: Stephanie W. Kanwit, Of Counsel, Epstein Becker Green

The Centers for Medicare & Medicaid Services (“CMS”) recently issued a final rule requiring hospitals to publicly disclose their rates, including negotiated rates with third-party payors regardless of product line, by January 1, 2021. The Final Rule’s intent is to increase price transparency so that health care consumers can “shop” for health care services. The Final Rule does not exclude any particular type of health plan, product, or line of business, except for rates that are not negotiated (e.g., fee-for-service Medicare or Medicaid). Hospitals that are deemed non-compliant are subject to fines of up to $300 per day, up to a maximum of $109,500 per year.

Despite issuance of Final rule on price transparency, the question remains if health care rates are too complicated to be “consumer friendly.” There are many hurdles that hospitals must overcome to meaningfully comply with the Final Rule, and it is questionable if they will even be able to provide useful data to consumers. And even if they are able to, it is questionable whether consumers will be able to make effective use of the data.

In addition to covering the provisions and scope of the Final Rule, and how the Final Rule would impact both hospitals and consumers when making health care decisions, this session will demonstrate by means of illustrative example how a potential patient could make use of the data required by the Final Rule and the limitations hospitals will have in providing reliable information.

Please join us on Thursday, February 6, 2020, at 1 PM Eastern as Epstein Becker Green's Stephanie W. Kanwit examines the provisions, complexities, challenges, implications and outcomes of the CMS Hospital Price Transparency Final Rule, in this special 45-minute HealthcareWebSummit event: Hospital Price Transparency Implications: Fallout from the CMS Final Rule Effective in 2021.

Registration Details

  • Individual Registration: $150
  • Individual Registration and Post-event materials - Includes webinar video and presentation pdf file: $195 for attendees
  • Post-event materials for non-attendees - Includes webinar video and presentation pdf file. Available after the event: $215

Register above or download a registration form. You can also register by phone: 209.577.4888. Corporate Site licensing also available. We look forward to your attendance!

MCOL Premium members receive a 50% discount on all Healthcare Web Summit events. Members can get the discount code on the Premium Member Website. Non-members can learn about MCOL Premium memberships and sign-up to get the 50% discount on this and future events.

Need a Printable Form? Download a registration form you can fax or mail.

Cure for the Common Webinar

In addition to the main faculty presentation, this event includes a fun whiteboard drawing format opening video, a brief moderated faculty interview, and concluding live audience questions and answers. The day before the event, you'll receive login information, including downloadable companion presentation slides.

Just after the event, you'll receive a follow-up request for feedback, also offering an opportunity to provide any final questions that can be forwarded to the faculty. Also, if you need support before, during or after the event, you can contact HealthcareWebSummit staff at any time.

Learning Objectives

After attending this webinar, attendees will be able to:

  • Understand the provisions set forth in the CMS Hospital Transparency Final Rule
  • Examine the complexities surrounding the scope of the Final Rule
  • Illustrate the challenge of making a hospital’s negotiated rates “consumer friendly” for individuals shopping for health care services
  • Consider the implications and outcomes for hospitals, consumers, and regulators after the Final Rule takes effect
  • Engage in interactive learning through online question submission, attendee feedback and opportunity for post-event follow up questions.

Who Should Attend

Interested attendees would include:

  • C-Suite Executives
  • Legal & Regulatory Executives and Staff
  • Compliance Executives and Staff
  • Finance Executives and Staff
  • Communications Executives and Staff
  • Marketing Executives and Staff
  • Business Development Executives and Staff
  • Managed Care Executives and Staff
  • Provider Network Executives
  • Planning and Strategic Executives and Staff
  • Business Intelligence Staff
  • Other Interested Parties

 Attendees would represent organizations including:

  • Hospitals and Health Systems
  • Provider Networks
  • Accountable Care Organizations
  • Health Plans
  • Solutions Providers
  • Consulting Organizations
  • Associations, Institutes and Research Organizations
  • Media
  • Other Interested Organizations

Faculty

Stephanie W. Kanwit

Stephanie W. Kanwit,
Of Counsel
Epstein Becker Green

 

Stephanie W. Kanwit is Of Counsel in the Health Care and Life Sciences practice, in the firm's Washington, DC, office. She has been in private law practice and government service in Chicago and Washington, DC, for nearly 40 years.

Ms. Kanwit’s experience includes:

  • Advising on health care regulatory matters, public policy, and strategic planning, including antitrust and competitive issues, government programs such as Medicare, and employee benefit plan (ERISA) issues
  • Defending lawsuits for managed care companies under both federal and state law
  • Counseling and writing amicus briefs for major health trade associations
  • Managing litigation involving antitrust, Medicare, ERISA, health care fraud and abuse, adverse medical outcomes, and life and long-term disability insurance issues

Before rejoining Epstein Becker Green in 2019 (she was a health care attorney and litigator at the firm until 2001), Ms. Kanwit served as Counsel of Health Care Transaction & Policy at a national law firm; as General Counsel for a Washington, DC-based insurance trade association that represents nearly 1,300 member companies providing health, long-term care, dental, disability, and supplemental coverage to more than 200 million Americans; and as Special Counsel for a trade association that represents pharmacy benefit managers and their health care partners in pharmaceutical care. For five years, Ms. Kanwit was Vice President of Health Litigation for a major health insurance company. Earlier in her career, she was in private practice with two Chicago law firms, where she represented both plaintiffs and defendants in complex commercial litigation, including antitrust and unfair trade practices. Additionally, she served for four years as regional director of the Federal Trade Commission (FTC) for a seven-state region.

Ms. Kanwit is regularly called upon by the American Bar Association (ABA), the American Health Lawyers Association (AHLA), and other policymaking groups to share her knowledge and insight in health law and policy developments. She has provided testimony on health care issues at the invitation of various government entities, including the U.S. Senate Committee on the Judiciary, the House Committee on Oversight and Government Reform, the FTC, and the U.S. Department of Justice. In addition, Ms. Kanwit previously taught Healthcare Competition as an Adjunct Professor at George Washington University’s School of Public Health.

 

View full details